Forms and strengths
- 4% cream (Rx; most products are marketed without FDA approval)
- Triple combination 4% hydroquinone / 0.05% tretinoin / 0.01% fluocinolone (Rx, the only FDA-approved product)
- Compounded higher strengths (Rx)
How to use it
Thin layer to the spots nightly for 8–12 weeks, then a break; daily broad-spectrum sunscreen is mandatory or the pigment returns. Many clinicians alternate with azelaic acid or tranexamic acid during breaks.
Side effects and cautions
- Irritation and redness
- Halo lightening around spots
- Exogenous ochronosis (blue-black discoloration) with prolonged or high-strength use
Not recommended in pregnancy. Stop and seek care if darkening or blue-black patches appear. Imported skin-lightening products have been found to contain mercury and undisclosed hydroquinone.
Regulatory status
Under the 2020 CARES Act, OTC hydroquinone is no longer legally marketed in the U.S.; FDA issued warning letters in 2022 and says the triple-combination cream is the only approved hydroquinone product. Banned in E.U. cosmetics; prescription elsewhere.
In the trends
Trending in the wrong direction: 'glow' creams from overseas marketplaces are where FDA keeps finding mercury and hydroquinone.
Sources on file
These links support the claims above. Reviewed September 1, 2026. Drug labels link to DailyMed searches so the current label is always one click away.
- U.S. FDA — protecting consumers from potentially harmful OTC skin lightening products (opens in a new tab)
- U.S. FDA — Skin Facts: what you need to know about skin lightening products (opens in a new tab)
- NIH DailyMed — hydroquinone labels (opens in a new tab)
- Int J Dermatol 2022 — exogenous ochronosis associated with hydroquinone: systematic review (PubMed) (opens in a new tab)
- Front Med 2021 — melasma treatments: network meta-analysis of RCTs (PubMed) (opens in a new tab)
- American Academy of Dermatology — melasma treatment (opens in a new tab)